Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy.

Da Huo1,2, Sen Liu2, Chao Zhang2

  • 1Department of Radiology, Drum Tower Hospital, School of Medicine, Nanjing University , Nanjing, Jiangsu 210008, China.

ACS Nano
|October 10, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-transforming hydrogel mimicking tertiary lymph nodes to activate cGAS-STING pathway for enhanced antitumor immunotherapy.

Science advances·2026
Same author

pH-Responsive Biomineralized Probiotic for Self-Amplifying Mucosal Vaccination: Gut-Engineered Antigen Factories Drive Targeted Cervical Tumor Regression.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Changes of bone, adipose, and muscle-related body compositions in gastric cancers after gastrectomy using deep learning based automatic segmentation.

BMC gastroenterology·2025
Same author

Protein-Confined Rotor Strategy for Quantum Yield Enhancement in Supramolecular Photosensitizers toward Sentinel Lymph Node-Targeted Photodynamic Immunoactivation.

ACS nano·2025
Same author

Correction to "Photothermally Reinforced Nanozyme Remodeling Tumor Microenvironment of Redox and Metabolic Homeostasis to Enhance the Ferroptosis in Tumor Therapy".

ACS nano·2025
Same author

Enhancing Chemotherapy Efficacy via an Autologous Erythrocyte-Anchoring Strategy with a Closed-System Drug-Transfer Device.

ACS biomaterials science & engineering·2024

This study introduces a novel nanocluster bomb that releases small nanoparticles to target tumor hypoxia. This approach enhances radiotherapy (RT) efficacy by improving tumor penetration and overcoming hypoxia-induced resistance.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Radiotherapy

Background:

  • Ultrasmall metal nanoparticles (NPs) show promise as radiosensitizers but suffer from rapid clearance and poor tumor penetration.
  • Tumor hypoxia presents a significant challenge in radiotherapy (RT), leading to treatment resistance.
  • Developing effective strategies to target tumor hypoxia and enhance RT is crucial for improved cancer treatment.

Purpose of the Study:

  • To develop a size-tunable nanocluster bomb for enhanced tumor targeting and radiotherapy.
  • To overcome the limitations of rapid clearance and poor penetration of traditional radiosensitizers.
  • To investigate the combined effects of photothermal ablation, radical species generation, and radiotherapy in hypoxic tumors.

Main Methods:

  • A size-tunable nanocluster bomb (initial size ~33 nm) was designed to release smaller NPs (~5 nm) for deep tumor penetration.
Keywords:
hypoxiananoparticlesphotothermal therapyradiosensitizationradiotherapytungsten

Related Experiment Videos

  • Nanoparticle-enhanced computed tomography (CT) was used for precise imaging of tumor hypoxia.
  • A 1064 nm laser was employed for CT-guided photothermal ablation and simultaneous radical species production.
  • The Akt-mTOR pathway was investigated for its role in hypoxia-induced resistance and radiosensitization.

    • Main Results:

    • The nanocluster bomb demonstrated a long half-life in circulation and successfully released hypoxia-targeting NPs.
    • NP-enhanced CT provided high-resolution imaging of tumor hypoxic profiles.
    • Combined photothermal ablation and radical species generation effectively alleviated hypoxia-induced resistance.
    • The treatment significantly sensitized tumors to radiotherapy in an Akt-mTOR pathway-dependent manner.
    • Successful therapeutic outcomes were observed in orthotopic breast and pancreatic cancer animal models.

    Conclusions:

    • The developed nanocluster bomb system offers a promising strategy for targeted delivery of radiosensitizers to hypoxic tumors.
    • The combination of CT-guided photothermal therapy, radical species generation, and radiotherapy effectively manages hypoxic tumors.
    • This approach holds potential for improving the efficacy of cancer treatment in challenging hypoxic tumor microenvironments.